(AOF) – Amoéba confirms the progress of its production site project dedicated to the biocontrol application and announces the signing of the deed of purchase of the land intended to accommodate this factory in Cavaillon in Vaucluse. This industrial biotech specializing in the treatment of microbiological risk emphasizes that the Usibiam project (Amoéba Biocontrol Factory) is completing its industrialization phase with a view to marketing its biocontrol solutions in early 2025.
This large-scale industrial project, costing around 45 million euros over the period 2023-2025 (23 million in investments and 22 million in operational expenses), already benefits from the support of Bpifrance to the tune of 5.9 million euros as part of the France 2030 program. Amoéba also announced financing of 9 million euros in the form of simple bonds with the Swiss company Nice & Green. The group continues to seek additional financing
© 2023 Agence Option Finance (AOF) – All reproduction rights reserved by AOF. AOF collects its data from the sources it considers the safest. However, the reader remains solely responsible for their interpretation and use of the information made available to them. The reader must therefore hold AOF and its contributors harmless from any claim resulting from this use. Agence Option Finance (AOF) is a brand of the Option Finance group
Did you like this article ? Share it with your friends using the buttons below.
